drugset / Trial / NCT07507643

A Study of Methylprednisolone in People Having Liver Surgery

NCT07507643

Phase 3 Recruiting 750 enrolled Memorial Sloan Kettering Cancer Center
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to test whether receiving methylprednisolone before surgery will reduce the side effects of having surgery, such as infections and longer hospital stays.

Timeline

Start
2026-03-27
Primary completion
2029-03-27
Completion
2029-03-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylprednisolone Other / unclassified

Indications

No indication recorded.